|Day's Range||36.0700 - 36.2513|
|52 Week Range||31.2400 - 36.7900|
|PE Ratio (TTM)||N/A|
|Expense Ratio (net)||0.12%|
Pfizer’s (PFE) revenues have been driven by growth in the sales of key products including Lyrica, Ibrance, Xalkori, and Xeljanz.
Over the last year, Eli Lilly’s (LLY) forward PE has traded in the range of 18.9x–25.5x.
Merck and Co. (MRK) will release its 1Q17 earnings on May 2, 2017. Analysts’ estimates show EPS of $0.83 on revenues of $9.25 billion for 1Q17.